SEC Form 4 · accession 0001144204-15-043131
Fortress Biotech, Inc. · FBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Avgerinos
Officer — SVP, Biologics Operations
Period of report
Jul 15, 2015
Accepted (ET)
Jul 17, 2015 · 4:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001429260
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 | holding | — | — | — | 8,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase Common StockF2,F1 | $9.21 | Jul 15, 2015 | D | 200,000 | D | — | Jun 4, 2023 | Common Stock | 200,000 | 0 | D |
Explanation of responses
- F1One-third of the shares will vest yearly beginning on June 4, 2014.
- F2The option was canceled by mutual agreement of the Reporting Person and the Issuer. The Reporting Person entered into a Restricted Stock Unit Award Agreement dated June 9, 2015 as consideration for the cancellation.